{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T08:34:08Z","timestamp":1790325248442,"version":"4.1.0"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejinme.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.ejim.2025.106600","type":"journal-article","created":{"date-parts":[[2025,11,23]],"date-time":"2025-11-23T20:14:12Z","timestamp":1763928852000},"page":"106600","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Cardiovascular Risk Assessment: Practical Tips for the Internal Medicine Specialist"],"prefix":"10.1016","volume":"145","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6611-4092","authenticated-orcid":false,"given":"Fernando A.","family":"Rivera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ridwan","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Trejo-Gutierrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"13","key":"10.1016\/j.ejim.2025.106600_bib0001","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1161\/CIRCULATIONAHA.115.016021","article-title":"Estimates of global and regional premature cardiovascular mortality in 2025","volume":"132","author":"Roth","year":"2015","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.ejim.2025.106600_bib0002","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1001\/jamacardio.2016.0991","article-title":"Risk of premature cardiovascular disease vs the number of premature cardiovascular events","volume":"1","author":"Sniderman","year":"2016","journal-title":"JAMA Cardio"},{"key":"10.1016\/j.ejim.2025.106600_bib0003","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ejim.2021.12.019","article-title":"The identity of the internist: a U.S. perspective","volume":"98","author":"Kane","year":"2022","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.ejim.2025.106600_bib0004","series-title":"Braunwald's heart disease: a textbook of cardiovascular medicine. publication date 2015. risk markers and the primary prevention of cardiovascular disease","author":"Mann","year":"1929"},{"issue":"12","key":"10.1016\/j.ejim.2025.106600_bib0005","doi-asserted-by":"crossref","DOI":"10.1161\/HCQ.0000000000000134","article-title":"The role of primary care in achieving life's Essential 8: a scientific statement from the American Heart Association","volume":"17","author":"Sterling","year":"2024","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"25","key":"10.1016\/j.ejim.2025.106600_bib0006","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1016\/j.jacc.2013.11.005","article-title":"2013 ACC\/AHA Guideline on the assessment of Cardiovascular Risk: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"63","author":"Goff","year":"2014","journal-title":"JACC Vol."},{"issue":"10","key":"10.1016\/j.ejim.2025.106600_bib0007","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1177\/2047487315588390","article-title":"Cardiovascular risk estimation in older persons: SCORE O.P","volume":"23","author":"Cooney","year":"2016","journal-title":"Eur J Prev Cardiol"},{"issue":"14","key":"10.1016\/j.ejim.2025.106600_bib0008","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1177\/2047487319846715","volume":"26","author":"Rossello","year":"2019","journal-title":"Eur J Prev Cardiol"},{"issue":"6","key":"10.1016\/j.ejim.2025.106600_bib0009","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1161\/CIRCULATIONAHA.123.067626","article-title":"ME Grams et al. for the Chronic Kidney Disease Prognosis Consortium and the American Heart Association Cardiovascular-Kidney-Metabolic Science Advisory Group. Development and validation of the American Heart Association\u2019s PREVENT equations","volume":"149","author":"Khan","year":"2024","journal-title":"Circulation"},{"issue":"20","key":"10.1016\/j.ejim.2025.106600_bib0010","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1161\/CIR.0000000000001184","article-title":"Cardiovascular-kidney-metabolic Health: a Presidential Advisory from the American Heart Association","volume":"148","author":"Ndumele","year":"2023","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.ejim.2025.106600_bib0011","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.38311","article-title":"Ade C. External validation of the American Heart Association PREVENT cardiovascular disease risk equations","volume":"7","author":"Scheuermann","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"18","key":"10.1016\/j.ejim.2025.106600_bib0012","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1001\/jama.2009.1619","article-title":"Major lipids, apolipoproteins, and risk of vascular disease","volume":"302","author":"Di Angelantonio","year":"2009","journal-title":"JAMA"},{"issue":"15","key":"10.1016\/j.ejim.2025.106600_bib0013","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/j.jacc.2015.07.066","article-title":"Implications of coronary artery calcium testing among statin candidates according to American College of Cardiology\/American Heart Association Cholesterol Management Guidelines: MESA (Multi-Ethnic Study of Atherosclerosis)","volume":"66","author":"Nasir","year":"2015","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.ejim.2025.106600_bib0014","first-page":"1259","article-title":"Coronary artery calcium for risk stratification of sudden cardiac death the Coronary artery calcium consortium","volume":"15","author":"Razavi","year":"2022","journal-title":"JACC: CARDIOVASCULAR IMAGING"},{"issue":"1","key":"10.1016\/j.ejim.2025.106600_bib0015","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13584-020-00375-4","article-title":"The patient-physician relationship: an account of the physician\u2019s perspective","volume":"9","author":"Berger","year":"2020","journal-title":"Isr J Health Policy Res"},{"issue":"1","key":"10.1016\/j.ejim.2025.106600_bib0016","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13584-020-00372-7","article-title":"Patient satisfaction with primary care physician performance in a multicultural population","volume":"9","author":"Hayek","year":"2020","journal-title":"Isr J Health Policy Res"},{"issue":"9","key":"10.1016\/j.ejim.2025.106600_bib0017","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1056\/NEJMp1109283","article-title":"Shared decision making\u2013pinnacle of patient-centered care","volume":"366","author":"Barry","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2025.106600_bib0018","doi-asserted-by":"crossref","DOI":"10.1161\/CIR.0000000000000638","article-title":"Use of risk assessment tools to guide decision-making in the primary prevention of atherosclerotic cardiovascular disease: a special report from the American Heart Association and American College of Cardiology","volume":"139","author":"Lloyd-Jones","year":"2019","journal-title":"Circulation."},{"issue":"6","key":"10.1016\/j.ejim.2025.106600_bib0019","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1161\/CIRCULATIONAHA.107.699579","article-title":"General cardiovascular risk profile for use in primary care: the Framingham Heart Study","volume":"117","author":"D'Agostino","year":"2008","journal-title":"Circulation. Volume"},{"issue":"18","key":"10.1016\/j.ejim.2025.106600_bib0020","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1161\/01.CIR.97.18.1837","article-title":"Prediction of coronary heart disease using risk factor categories","volume":"97","author":"Wilson","year":"1998","journal-title":"Circulation"},{"issue":"14","key":"10.1016\/j.ejim.2025.106600_bib0021","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1001\/jama.2014.2630","article-title":"Validation of the atherosclerotic cardiovascular disease pooled cohort risk equations","volume":"311","author":"Muntner","year":"2014","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.ejim.2025.106600_bib0022","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.mayocp.2016.03.019","article-title":"Predictive validity of the American College of Cardiology\/American Heart Association pooled cohort equations in predicting all-cause and cardiovascular disease specific mortality in a national prospective cohort study of adults in the United States","volume":"91","author":"Loprinzini","year":"2016","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.ejim.2025.106600_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacc.2023.08.024","article-title":"The pooled cohort equations and the test of time","volume":"82","author":"Lloyd-Jones","year":"2023","journal-title":"JACC"},{"issue":"4","key":"10.1016\/j.ejim.2025.106600_bib0024","article-title":"PREVENT equations: a new era in cardiovascular disease risk assessment","volume":"17","author":"Razavi","year":"2024","journal-title":"Circulation: Cardiovascular Quality and Outcomes"},{"key":"10.1016\/j.ejim.2025.106600_bib0025","doi-asserted-by":"crossref","first-page":"j2099","DOI":"10.1136\/bmj.j2099","article-title":"Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study","volume":"357","author":"Hippisley-Cox","year":"2017","journal-title":"BMJ"},{"issue":"19","key":"10.1016\/j.ejim.2025.106600_bib0026","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1161\/CIRCULATIONAHA.116.022367","article-title":"Predicting the 10-year risks of atherosclerotic cardiovascular disease in Chinese population: the China-PAR project (prediction for ASCVD risk in China","volume":"134","author":"Yang","year":"2016","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.ejim.2025.106600_bib0027","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1253\/circj.70.960","article-title":"The NIPPON DATA 80 Research Group. Combined Cardiovascular Risk Factors and Outcome. NIPPON DATA80, 1980-1994","volume":"70","author":"Nakamura","year":"2006","journal-title":"Circulation Journal"},{"issue":"8","key":"10.1016\/j.ejim.2025.106600_bib0028","doi-asserted-by":"crossref","first-page":"736","DOI":"10.4070\/kcj.2024.0411","article-title":"Korean cardiovascular health status assessed by life's essential 8 in Korean adult population: based on data from the Korean National Health and Nutrition Examination Survey 2014\u20132021","volume":"55","author":"Choi","year":"2025","journal-title":"Korean Circ J"},{"key":"10.1016\/j.ejim.2025.106600_bib0029","first-page":"e1332","volume":"7","year":"2019"},{"issue":"5","key":"10.1016\/j.ejim.2025.106600_bib0030","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1067\/mhj.2001.114974","article-title":"INTER-HEART: a global study of risk factors for acute myocardial infarction","volume":"141","author":"Ounpuu","year":"2001","journal-title":"Am Heart J"},{"key":"10.1016\/j.ejim.2025.106600_bib0031","article-title":"Incorporating coronary calcium scoring into risk assessment for primary prevention","volume":"14","author":"Lloyd-Jones","year":"2021","journal-title":"JACC: Cardiovascular Imaging"},{"issue":"7","key":"10.1016\/j.ejim.2025.106600_bib0032","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s12170-019-0616-y","article-title":"The use of risk enhancing factors to personalize ASCVD risk assessment: evidence and recommendations from the 2018 AHA\/ACC Multi-society Cholesterol guidelines","volume":"13","author":"Agarwala","year":"2019","journal-title":"Curr Cardiovasc Risk Rep"},{"issue":"19","key":"10.1016\/j.ejim.2025.106600_bib0033","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1161\/CIRCULATIONAHA.119.045010","article-title":"Coronary artery calcium for personalized allocation of aspirin in primary prevention of cardiovascular disease in 2019: the MESA study (Multi-Ethnic Study of Atherosclerosis)","volume":"141","author":"Cainzos-Achirica","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2025.106600_bib0034","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1161\/CIRCULATIONAHA.115.016846","article-title":"Utility of nontraditional risk markers in individual ineligible for statin therapy according to the 2013 American College of Cardiology\/American Heart Association cholesterol guidelines","volume":"132","author":"Yeboah","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2025.106600_bib0035","first-page":"411","article-title":"Comparing risk scores in the prediction of coronary and cardiovascular deaths: coronary Artery Calcium Consortium","volume":"14","author":"Blaha","year":"2021","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.ejim.2025.106600_bib0036","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.jacc.2018.05.027","article-title":"Coronary calcium score and cardiovascular risk","volume":"72","author":"Greenland","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"10.1016\/j.ejim.2025.106600_bib0037","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1001\/jama.2024.12537","article-title":"Projected changes in statin and antihypertensive therapy eligibility with the AHA PREVENT cardiovascular risk equations","volume":"332","author":"Diao","year":"2024","journal-title":"JAMA"},{"issue":"13","key":"10.1016\/j.ejim.2025.106600_bib0038","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1177\/2047487317717346","article-title":"Prevention of cardiovascular disease in patients with familial hypercholesterolemia: the role of PCSK9 inhibitors","volume":"24","author":"Pe\u0107in","year":"2017","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.ejim.2025.106600_bib0039","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.124.038915","article-title":"Population impact of using the PREVENT equations to guide the management of stage 1 hypertension in the United States","volume":"14","author":"Drexler","year":"2025","journal-title":"J Am Heart Assoc"},{"issue":"3","key":"10.1016\/j.ejim.2025.106600_bib0040","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jacc.2025.04.066","article-title":"AHA PREVENT equations and cardiovascular disease risk in diverse health care populations","volume":"86","author":"Cho","year":"2025","journal-title":"JACC Volume"},{"key":"10.1016\/j.ejim.2025.106600_bib0041","doi-asserted-by":"crossref","DOI":"10.1001\/jamacardio.2025.1865","article-title":"Performance of the American Heart Association\u2019s PREVENT equations among disaggregated racial and ethnic subgroups","author":"Yan","year":"2025","journal-title":"JAMA Cardiol. Published Online:"},{"issue":"3","key":"10.1016\/j.ejim.2025.106600_bib0042","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jacc.2025.04.066","article-title":"AHA PREVENT equations and cardiovascular disease risk in diverse health care populations","volume":"86","author":"Cho","year":"2025","journal-title":"JACC"},{"issue":"3","key":"10.1016\/j.ejim.2025.106600_bib0043","article-title":"Atherosclerotic cardiovascular disease risk prediction models in China, Japan, and Korea. Implications for East Asians?","volume":"5","author":"Nguyen","year":"2025","journal-title":"American College of Cardiology"},{"issue":"2","key":"10.1016\/j.ejim.2025.106600_bib0044","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1177\/2047487319893035","article-title":"Update on cardiovascular prevention in clinical practice: a position paper of the European Association of Preventive Cardiology of the European Society of Cardiology","volume":"27","author":"Piepoli","year":"2020","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.ejim.2025.106600_bib0045","first-page":"e563","article-title":"2019 ACC\/AHA Guideline on the primary prevention of Cardiovascular Disease: executive summary A report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice","volume":"140","author":"Arnett","year":"2019","journal-title":"Guidelines. Circulation."},{"issue":"8","key":"10.1016\/j.ejim.2025.106600_bib0046","article-title":"Optimizing cardiovascular health: a comprehensive review of risk assessment strategies for primary prevention","volume":"16","author":"Karwa","year":"2024","journal-title":"Cureus"},{"issue":"11","key":"10.1016\/j.ejim.2025.106600_bib0047","first-page":"e596","article-title":"2019 ACC\/AHA Guideline on the primary prevention of Cardiovascular Disease: a report of the American College of Cardiology\/American Heart Association Task Force on clinical Practice Guidelines","volume":"140","author":"Arnett","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2025.106600_bib0048","doi-asserted-by":"crossref","unstructured":"S.S. Virani, S.C. Smith Jr, N.J. Stone, and S.M. Grundy. Secondary prevention for atherosclerotic cardiovascular disease: comparing recent US and European guidelines on dyslipidemia. Circulation. Volume 141, Number 14. https:\/\/doi.org\/10.1161\/Circulation.AHA.119.044282.","DOI":"10.1161\/CIRCULATIONAHA.119.044282"},{"issue":"3","key":"10.1016\/j.ejim.2025.106600_bib0049","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1055\/s-0041-1731273","article-title":"Current status of primary, secondary, and tertiary prevention of coronary artery disease","volume":"30","author":"Prasad","year":"2021","journal-title":"Int J Angiol"},{"issue":"Supplement_1","key":"10.1016\/j.ejim.2025.106600_bib0050","doi-asserted-by":"crossref","first-page":"i16","DOI":"10.1093\/eurheartjsupp\/suae100","article-title":"Cardiovascular risk assessment in daily clinical practice: when and how to use a risk score","volume":"27","author":"Panattoni","year":"2025","journal-title":"European Heart Journal Supplements"},{"issue":"34","key":"10.1016\/j.ejim.2025.106600_bib0051","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","article-title":"2021 ESC guidelines on cardiovascular disease prevention in clinical practice","volume":"42","author":"Visseren","year":"2021","journal-title":"Eur Heart J"},{"issue":"28","key":"10.1016\/j.ejim.2025.106600_bib0052","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1093\/eurheartj\/ehaa209","article-title":"The Mediterranean diet, plasma metabolome, and cardiovascular disease risk","volume":"41","author":"Li","year":"2020","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.ejim.2025.106600_bib0053","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.pcad.2015.04.003","article-title":"Benefits of the Mediterranean diet: insights from the PREDIMED study","volume":"58","author":"Mart\u00ednez-Gonz\u00e1lez","year":"2016","journal-title":"Prog Cardiovasc Dis"},{"issue":"2","key":"10.1016\/j.ejim.2025.106600_bib0054","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJMoa1212914","article-title":"The Look AHEAD Research Group. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes","volume":"369","year":"2013","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.ejim.2025.106600_bib0055","first-page":"98","article-title":"Major global coronary artery calcium guidelines","volume":"16","author":"Golub","year":"2022","journal-title":"JACC: Cardiovascular Imaging"},{"key":"10.1016\/j.ejim.2025.106600_bib0056","article-title":"Coronary artery calcium staging to guide preventive interventions. A proposal and call to action","volume":"3","author":"Maron","year":"2024","journal-title":"JACC: Advances"},{"key":"10.1016\/j.ejim.2025.106600_bib0057","doi-asserted-by":"crossref","unstructured":"N. Marx, M. Husain, M. Lehrke, S. Verma, and N. Sattar. GLP-1 receptor agonists for the reduction of atherosclerotic cardiovascular risk in patients with type 2 diabetes. Volume 146, Issue 24, 13 December 2022; Pages 1882\u201394. doi:10.1161\/Circulation.AHA.122.059595.","DOI":"10.1161\/CIRCULATIONAHA.122.059595"},{"issue":"25","key":"10.1016\/j.ejim.2025.106600_bib0058","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1016\/j.jacc.2023.04.034","article-title":"Effect of SGLT2 inhibitors on cardiovascular outcomes across various patient populations","volume":"81","author":"Usman","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ejim.2025.106600_bib0059","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S2213-8587(19)30084-1","article-title":"Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement","volume":"7","author":"Neeland","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"8","key":"10.1016\/j.ejim.2025.106600_bib0060","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1001\/jamacardio.2022.1876","article-title":"Comparison of statin eligibility by ACC\/AHA vs ESC SCORE2 criteria (Copenhagen General Population Study)","volume":"7","author":"Mortensen","year":"2022","journal-title":"JAMA Cardiol"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620525004777?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620525004777?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T02:28:03Z","timestamp":1785205683000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620525004777"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":60,"alternative-id":["S0953620525004777"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2025.106600","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiovascular Risk Assessment: Practical Tips for the Internal Medicine Specialist","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2025.106600","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 European Federation of Internal Medicine. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106600"}}